scholarly journals Maternal body mass index and country of birth in relation to the adverse outcomes of large for gestational age and gestational diabetes mellitus in a retrospective cohort of Australian pregnant women

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Catherine R. Knight-Agarwal ◽  
Rati Jani ◽  
Meisa Al Foraih ◽  
Dionne Eckley ◽  
Carrie Ka Wai Lui ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Body Mass ◽  
Gestational Age ◽  
Adverse Outcomes ◽  
Large For Gestational Age ◽  
Maternal Body Mass Index ◽  
Country Of Birth

Abstract Background The prevalence of gestational diabetes mellitus in Australia has been rising in line with the increased incidence of maternal overweight and obesity. Women with gestational diabetes mellitus, high body mass index or both are at an elevated risk of birthing a large for gestational age infant. The aim was to explore the relationship between country of birth, maternal body mass index with large for gestational age, and gestational diabetes mellitus. In addition to provide additional information for clinicians when making a risk assessment for large for gestational age babies. Method A retrospective cohort study of 27,814 women residing in Australia but born in other countries, who gave birth to a singleton infant between 2008 and 2017 was undertaken. Logistic regression analysis was used to examine the association between the aforementioned variables. Results A significantly higher proportion of large for gestational age infants was born to overweight and obese women compared to those who were classified as underweight and healthy weight. Asian-born women residing in Australia, with a body mass index of ≥40 kg/m2, had an adjusted odds ratio of 9.926 (3.859–25.535) for birthing a large for gestational age infant. Conversely, Australian-born women with a body mass index of ≥40 kg/m2 had an adjusted odds ratio of 2.661 (2.256–3.139) for the same outcome. Women born in Australia were at high risk of birthing a large for gestational age infant in the presence of insulin-requiring gestational diabetes mellitus, but this risk was not significant for those with the diet-controlled type. Asian-born women did not present an elevated risk of birthing a large for gestational age infant, in either the diet controlled, or insulin requiring gestational diabetes mellitus groups. Conclusions Women who are overweight or obese, and considering a pregnancy, are encouraged to seek culturally appropriate nutrition and weight management advice during the periconception period to reduce their risk of adverse outcomes.

scholarly journals Maternal Body Mass Index and Ethnicity in Relation to The Adverse Outcomes of Large for Gestational Age and Gestational Diabetes Mellitus in a Retrospective Cohort of Australian Pregnant Women.

2021 ◽  
Author(s):  
Catherine Knight-Agarwal ◽  
Jani Rati ◽  
Meisa Al-Foraih ◽  
Dionne Eckley ◽  
Carrie Ka Wai Lui ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Body Mass ◽  
Gestational Age ◽  
Retrospective Cohort ◽  
Adverse Outcomes ◽  
Large For Gestational Age ◽  
Maternal Body Mass Index

Abstract Background: The prevalence of maternal overweight and obesity has been increasing. This research explored the association between maternal body mass index and ethnicity in relation to the adverse outcomes of large for gestational age and gestational diabetes mellitus. Method: A retrospective cohort study was undertaken with 27 814 Australian women of various ethnicities, who gave birth to a singleton infant between 2008 and 2017. Variables were examined using logistic regression. Results: A significantly higher proportion of large for gestational age infants were born to overweight and obese women compared to those who were classified as underweight and healthy weight. Asian-born women with a body mass index of ≥ 40kg/m2 had an adjusted odds ratio of 9.926 (3.859 - 25.535) for birthing a large for gestational age infant whereas Australian-born women had an adjusted odds ratio of 2.661 (2.256 - 3.139) for the same outcome. Women born in Australia were at high risk of birthing a large for gestational age infant in the presence of insulin controlled gestational diabetes mellitus, but this risk was not significant for those with the diet-controlled type. Asian-born women did not present an elevated risk of birthing a large for gestational infant, in either the diet controlled, or insulin controlled gestational diabetes mellitus groups. Conclusion: Large for gestational age and gestational diabetes mellitus are adverse pregnancy outcomes that can lead to significant maternal and neonatal morbidity. Women who are overweight or obese, and considering a pregnancy, are encouraged to seek culturally appropriate nutrition and weight management advice during the periconception period.

scholarly journals Screening of gestational diabetes mellitus using fasting plasma glucose before the 24th gestational week in women with different pre-pregnancy body mass index

2020 ◽  
Vol 7 (2) ◽  
pp. 218
Author(s):  
Sambit Das ◽  
Mahesh Rath ◽  
Lipsa Das ◽  
Kasturi Bharadwaj
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Body Mass ◽  
Gestational Age ◽  
Overweight And Obesity ◽  
Oral Glucose ◽  
Gestational Week ◽  
Overweight Or Obesity

Background: Gestational Diabetes Mellitus (GDM) is usually diagnosed between 24th and 28th gestational week using the 75-g Oral Glucose Tolerance Test (OGTT). It is controversial that if FPG ≥92 mg/dL before 24th gestational week should be intervened or not. The aim of this study was to evaluate the value of FPG to screen GDM before 24th gestational week in women with different pre-pregnancy Body Mass Index (BMI).Methods: This was a hospital based retrospective cohort study done at CHC Balipatna, Khurdha, Odisha. Women who had a singleton live birth between June 20, 2016 and June 30, 2019, resided in Balipatna block area and received prenatal care in the Community Health Centre, were included in this study. Pre-pregnancy BMI, FPG before the 24th gestational week, and one-step GDM screening with 75 g-OGTT at the 24th to 28th gestational weeks were extracted from medical records and analyzed. The pregnant women were classified into four groups based on pre-pregnancy BMI: Group A (underweight), Group B (normal), Group C (overweight) and Group D (obesity). Statistical analysis using independent sample t-test, Analysis of Variance (ANOVA) and Pearson Chi-square test was done.Results: The prevalence of GDM was 20.0% (68/341) in the study population. FPG decreased gradually as the gestational age increased in all pre-pregnancy BMI groups until the 19th gestational week. The incidence of GDM in women with FPG ≥92 mg/dL in the 19th to 24th gestational weeks and pre-pregnancy overweight or obesity was significantly higher than that in women with FPG ≥92 mg/dL and pre-pregnancy BMI <24.0 kg/m2.Conclusions: FPG decreased gradually as the gestational age increased in all pre-pregnancy BMI groups until the 19th gestational week. Pre-pregnancy overweight or obesity was associated with an increased FPG value before the 24th gestational week. FPG ≥92 mg/dL between 19 and 24 gestational weeks should be treated as GDM in women with pre-pregnancy overweight and obesity.

scholarly journals Effects of pre-pregnancy maternal body mass index on gestational diabetes mellitus

2018 ◽  
Vol 7 (1.9) ◽  
pp. 279 ◽  
Author(s):  
Priya Shirley Muller ◽  
M Nirmala
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Body Mass ◽  
Overweight And Obesity ◽  
Maternal Body Mass Index ◽  
Maternal Body ◽  
Good Glycaemic Control ◽  
Fetal Complications

The prevalence of both obesity and Gestational Diabetes Mellitus (GDM) is increasing worldwide. Overweight and obesity are abnormal or excessive fat accumulation that presents a risk to health. The presence of obesity has, in particular, a significant impact on both maternal and fetal complications associated with GDM. These complications can be addressed, at least in part, by good glycaemic control during pregnancy. The objective of the study is to classify GDM and non-GDM patients based on pre-pregnancy maternal Body Mass Index (BMI) and to assess and quantify the risk for GDM according to BMI.

scholarly journals Maternal Body Mass Index Is a Predictor of Neonatal Hypoglycemia in Gestational Diabetes Mellitus

2012 ◽  
Vol 97 (5) ◽  
pp. 1623-1628 ◽  
Author(s):  
Apolonia García-Patterson ◽  
Anna Aulinas ◽  
Miguel Ángel María ◽  
Justa Úbeda ◽  
Inmaculada Orellana ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Body Mass ◽  
Maternal Body Mass Index ◽  
Neonatal Hypoglycemia ◽  
Maternal Body

Thyroid function in pregnant women; relation to Gestational Diabetes Mellitus (GDM) and Body Mass Index (BMI)

2018 ◽  
Author(s):  
George Simeakis ◽  
Evangelia Vogiatzi ◽  
Panagiota Konstantakou ◽  
Evangelia Zapanti ◽  
Katerina Saltiki ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Pregnant Women ◽  
Body Mass ◽  
Thyroid Function

Gestationsdiabetes

2021 ◽  
Vol 19 (07) ◽  
pp. 312-316
Author(s):  
Delnaz Fard ◽  
Lars Brodowski ◽  
Constantin S. von Kaisenberg
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Body Mass ◽  
Gestational Age ◽  
Medikamentöse Therapie ◽  
Diabetes Mellitus Typ 2 ◽  
Large For Gestational Age ◽  
Kardiovaskuläre Ereignisse ◽  
Schwangerschaftsinduzierte Hypertonie

ZUSAMMENFASSUNGZiel: Review der Literatur zu Schwangeren mit Gestationsdiabetes, die ein erhöhtes peripartales Risiko aufweisen, welches im Rahmen des geburtshilflichen Managements Beachtung finden sollte.Methodik: Systematische Literaturrecherche.Ergebnisse: Als Gestationsdiabetes wird ein erstmals in der Schwangerschaft auftretender bzw. diagnostizierter Diabetes bezeichnet. Die Pathophysiologie und das Risikoprofil entsprechen dem des Diabetes mellitus Typ 2. Eine entscheidende Rolle spielen dabei, neben einer genetischen Disposition, der mütterliche Body-Mass-Index, der Lebensstil sowie frühere Schwangerschaften mit Gestationsdiabetes. Die Diagnosestellung erfolgt durch einen 75 g oralen Glukosetoleranztest, meist bei 24–28 Schwangerschaftswochen. Die Folgen für die Mutter sind vor allem die schwangerschaftsinduzierte Hypertonie und Präeklampsie sowie im Verlauf die erhöhte Inzidenz für kardiovaskuläre Ereignisse. Intrapartal zeigen sich zudem eine erhöhte Sectio-Rate bei fetalem Large for gestational age und ein erhöhtes Risiko für höhergradige Geburtsverletzungen und atone Nachblutungen. Die Therapie schließt sowohl die Lifestyle-Modifikation als auch die medikamentöse Therapie mit Insulin ein.Schlussfolgerungen: Durch die frühzeitige Diagnosestellung durch adäquate Testverfahren und konsequent eingeleitete Therapien kann das peripartale maternale und fetale Risiko reduziert werden.

Sign in / Sign up

Export Citation Format

Share Document